Skip to main content Skip to section navigation Skip to footer
Immunovant, Inc.
  • Home
  • About Us
  • Pipeline
    • Mechanism of Action
    • Indications
  • For Investors
    • Overview
    • Immunovant R&D Day
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Analyst Coverage
    • Governance
  • Join Us
    • Our Benefits
    • Our Careers
  • Contact Us

Governance Documents

For Investors

For Investors

  • Overview
  • Immunovant R&D Day
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Analyst Coverage
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Governance

  • Overview
  • Board of Directors
  • Board Committees
  • Governance Documents

Code of Business Conduct and Ethics

Download Code of Business Conduct and Ethics

Corporate Governance Guidelines

Download Corporate Governance Guidelines

Whistleblower Policy

Download Whistleblower Policy

Audit Committee Charter

Download Audit Committee Charter

Compensation Committee Charter

Download Compensation Committee Charter

Nominating and Corporate Governance Committee Charter

Download Nominating and Corporate Governance Committee Charter
  • Email Alerts
  • Contacts
  • RSS News Feed
©2023 Immunovant, Inc. All Rights Reserved.
Privacy Policy Terms of Use Disclaimer Sitemap Manage Cookie Preferences